PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8768358

Case study: neuroleptic malignant syndrome without pyrexia.

A F Hynes·E L Vickar
View original source ↗Export metadata ↓

Abstract

Fever is generally considered to be an essential feature of neuroleptic malignant syndrome (NMS). The authors present the case of a 12-year-old boy who had many features of NMS but did not have fever. This case emphasizes the importance of assessing the total clinical situation. It also supports the concept of neuroleptic-induced catatonia (NIC) and NMS as disorders on the same spectrum. A scoring system is offered as a guide to severity of NIC-NMS.

Explore related subjects

Antipsychotic AgentsChildDose-Response Relationship, DrugDrug Administration ScheduleFeverHaloperidolHumansMaleNeuroleptic Malignant SyndromeNeurologic ExaminationPsychiatric Status Rating ScalesSchizophrenia, ChildhoodCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A F Hynes, E L Vickar. 1996. Case study: neuroleptic malignant syndrome without pyrexia.. https://doi.org/10.1097/00004583-199607000-00024

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Differential pharmacology of atypical antipsychotics: clinical implications.

PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.

Antipsychotic Agents↗